Acceptability, Representations and Experiences of the COVID-19 Pandemic (ARECOVID)

August 5, 2021 updated by: Centre Hospitalier Universitaire de Saint Etienne

Acceptability, Representations and Experiences of the COVID-19 Pandemic : the ARECOVID Project

The "ARECOVID" project is a comprehensive sociological study of what is being played out in organizational terms in the face of the COVID-19 pandemic. Through quantitative methods (questionnaires) and qualitative methods (semi-directive interviews), we would understand the essential views of the populations concerned by COVID-19, but also that of actors taking care of vulnerable elderly non-COVID. Special attention will be paid to the care pathway of elderly people with and without the virus, in a health system in full reorganization. We will try to understand the needs and experiences of all health actors (hospital/city) involved in COVID-19 and the experience of confinement and the Covid-19 of the elderly living at home, in order to reflect on a possible improvement in the health response of elderly people in the event of an epidemic health crisis.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

understand the needs and experiences of all health actors (hospital/city) involved in COVID-19 and the experience of confinement and the Covid-19 of the elderly living at home

Study Type

Observational

Enrollment (Actual)

520

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Saint-Étienne, France
        • Gérontopole AURA

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Older 65 people Caregivers who works in gerontology

Description

Inclusion Criteria:

  • For older people : minimum age : 65 years
  • For caregivers : works in gerontology

Exclusion Criteria:

  • Person with a neurological disease
  • Person under guardianship or curatorship

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Caregivers
Caregivers who work with older patients will be included. They will have a questionnaire
Other: Questionnaire
Questions about the impact of COVID-19 in their works
Older
Older 65 people who live alone in their house will be included. They will have Individual interviews.
Other: Individual interview
Discussion between the searcher and the participant about representations of COVID-19 and experiences about confinement.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Analysis representations of COVID-19 and confinement of older people
Time Frame: Day 20
Measure by individual interviews
Day 20

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Analysis impacts of COVID-19 in works of caregivers
Time Frame: Day 20
Measure by questionnaire
Day 20

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Centre Hospitalier Universitaire de Saint Etienne

Collaborators

Gerontopole Auvergne Rhone-Alpes (AURA)
Ecole des Mines de Saint-Etienne
Université Jean Monnet - Chaire Santé des Ainés

Investigators

  • Study Chair: Pauline Gouttefarde, Gerontopole Auvergne Rhone-Alpes (AURA)

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2020

Primary Completion (Actual)

July 30, 2020

Study Completion (Actual)

July 30, 2020

Study Registration Dates

First Submitted

August 5, 2021

First Submitted That Met QC Criteria

August 5, 2021

First Posted (Actual)

August 6, 2021

Study Record Updates

Last Update Posted (Actual)

August 6, 2021

Last Update Submitted That Met QC Criteria

August 5, 2021

Last Verified

August 1, 2021

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • GA-2021-02

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aging

Clinical Trials on Questionnaire

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bangladesh

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe